STM publisher Elsevier, Netherlands, has announced that its journal Molecular Oncology (Molonc) has been accepted by Thomson Reuters for inclusion in the Science Citation Index Expanded (SciSearch), Biosis Previews and Biological Abstracts. Elsevier publishes the journal on behalf of the Federation of European Biochemical Societies (FEBS).
The inclusion in the SciSearch index is claimed to be an exceptional achievement for a journal that is just 18 months old in a fast-moving and highly competitive field. The 2009 Impact Factor will be the first for MOLONC. Coverage starts from Volume 1, 2007.
Molonc, published six times a year from January 1, 2009, highlights new discoveries, approaches and technical developments in basic, clinical and discovery-driven translational research. The first issue was published in June 2007 and has been managed from its inception by Prof. Julio E. Celis, Director of the Institute of Cancer Biology at the Danish Cancer Society in Copenhagen. It covers reviews, original articles, technical notes, editorials, news and views (commentary, science policy issues, ethical and legal issues, patient organisations, industry needs and alliances, regulatory issues, news items), letters to the editor, conference announcements and advertisements. The journal also publishes thematic issues.
FEBS has created various scientific publication forums for European life scientists by its two leading journals, the FEBS Journal and FEBS Letters. The organisation is a federation of learned societies with over 40,000 members and a charity established for the public benefit to advance research and education in biochemistry and molecular biology and related life sciences.
